The secretion and maturation of prosaposin and procathepsin D are blocked in embryonic neural progenitor cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1783, Issue 8, 2008, Pages 1480-1489

  Salvioli, Rosa ^a   Ricci Vitiani, Lucia ^a   Tatti, Massimo ^a   Scarpa, Susanna ^b   De Maria, Ruggero ^a   Vaccaro, Anna Maria ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alternative mRNA splicing; Human neural stem cells; Post translational modifications; Procathepsin D; Prosaposin; Protein secretion

Indexed keywords

CATHEPSIN; CATHEPSIN D; N ACETYL BETA GLUCOSAMINIDASE; PROCATHEPSIN; PROSAPOSIN; SPHINGOLIPID ACTIVATOR PROTEIN;

APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN DEVELOPMENT; CELL DIFFERENTIATION; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYONIC STEM CELL; HUMAN; HUMAN CELL; NERVE REGENERATION; NEURAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SECRETION;

ALTERNATIVE SPLICING; CATHEPSIN D; CELL DIFFERENTIATION; CELLS, CULTURED; ENZYME PRECURSORS; GLYCOSIDE HYDROLASES; HUMANS; NEURONS; OLFACTORY BULB; PROTEIN PRECURSORS; SAPOSINS; STEM CELLS;

EID: 46549084060     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.01.033     Document Type: Article

References (57)

1. O'Brien J.S., and Kishimoto Y. Saposin proteins: structure, function, and role in human lysosomal storage disorders. FASEB J. 5 (1991) 301-308
2. Kishimoto Y., Hiraiwa M., and O'Brien J.S. Saposins: structure, function, distribution, and molecular genetics. J. Lipid Res. 33 (1992) 1255-1267
3. Spiegel R., Bach G., Sury V., Mengistu G., Meidan B., Shalev S., Shneor Y., Mandel H., and Zeigler M. A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of a saposin A deficiency in humans. Mol. Genet. Metab. 84 (2005) 160-166
4. Wenger D.A., DeGala G., Williams C., Taylor H.A., Stevenson R.E., Pruitt J.R., Miller J., Garen P.D., and Balentine J.D. Clinical, pathological, and biochemical studies on an infantile case of sulfatide/GM1 activator protein deficiency. Am. J. Med. Genet. 33 (1989) 255-265
5. Schlote W., Harzer K., Christomanou H., Paton B.C., Kustermann-Kuhn B., Schmid B., Seeger J., Beudt U., Schuster I., and Langenbeck U. Sphingolipid activator protein 1 deficiency in metachromatic leucodystrophy with normal arylsulphatase A activity. A clinical, morphological, biochemical, and immunological study. Eur. J. Pediatr. 150 (1991) 584-591
6. Christomanou H., Chabas A., Pampols T., and Guardiola A. Activator protein deficient Gaucher's disease. A second patient with the newly identified lipid storage disorder. Klin. Wochenschr. 67 (1989) 999-1003
7. Matsuda J., Kido M., Tadano-Aritomi K., Ishizuka I., Tominaga K., Toida K., Takeda E., Suzuki K., and Kuroda Y. Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse. Hum. Mol. Genet. 13 (2004) 2709-2723
8. Zhou D., Cantu III C., Sagiv Y., Schrantz N., Kulkarni A.B., Qi X., Mahuran D.J., Morales C.R., Grabowski G.A., Benlagha K., Savage P., Bendelac A., and Teyton L. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303 (2004) 523-527
9. Winau F., Schwierzeck V., Hurwitz R., Remmel N., Sieling P.A., Modlin R.L., Porcelli S.A., Brinkmann V., Sugita M., Sandhoff K., Kaufmann S.H., and Schaible U.E. Saposin C is required for lipid presentation by human CD1b. Nat. Immunol. 5 (2004) 169-174
10. Kondoh K., Hineno T., Sano A., and Kakimoto Y. Secretion of sphingolipid hydrolase activator precursor, prosaposin. Biochem. Biophys. Res. Commun. 181 (1991) 286-292
11. Sylvester S.R., Skinner M.K., and Griswold M.D. A sulfated glycoprotein synthesized by Sertoli cells and by epididymal cells is a component of the sperm membrane. Biol. Reprod. 31 (1984) 1087-1101
12. Hiraiwa M., O'Brien J.S., Kishimoto Y., Galdzicka M., Fluharty A.L., Ginns E.I., and Martin B.M. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins). Arch. Biochem. Biophys. 304 (1993) 110-116
13. Lefrancois S., May T., Knight C., Bourbeau D., and Morales C.R. The lysosomal transport of prosaposin requires the conditional interaction of its highly conserved d domain with sphingomyelin. J. Biol. Chem. 277 (2002) 17188-17199
14. Zhao Q., and Morales C.R. Identification of a novel sequence involved in lysosomal sorting of the sphingolipid activator protein prosaposin. J. Biol. Chem. 275 (2000) 24829-24839
15. Lefrancois S., Zeng J., Hassan A.J., Canuel M., and Morales C.R. The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin. EMBO J. 22 (2003) 6430-6437
16. Hiraiwa M., Martin B.M., Kishimoto Y., Conner G.E., Tsuji S., and O'Brien J.S. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside. Arch. Biochem. Biophys. 341 (1997) 17-24
17. Sun Y., Witte D.P., and Grabowski G.A. Developmental and tissue-specific expression of prosaposin mRNA in murine tissues. Am. J. Pathol. 145 (1994) 1390-1398
18. Sun Y., Witte D.P., Jin P., and Grabowski G.A. Analyses of temporal regulatory elements of the prosaposin gene in transgenic mice. Biochem. J. 370 (2003) 557-566
19. Sano A., Hineno T., Mizuno T., Kondoh K., Ueno S., Kakimoto Y., and Inui K. Sphingolipid hydrolase activator proteins and their precursors. Biochem. Biophys. Res. Commun. 165 (1989) 1191-1197
20. Kondoh K., Sano A., Kakimoto Y., Matsuda S., and Sakanaka M. Distribution of prosaposin-like immunoreactivity in rat brain. J. Comp. Neurol. 334 (1993) 590-602
21. Kreda S.M., Fujita N., and Suzuki K. Expression of sphingolipid activator protein gene in brain and systemic organs of developing mice. Dev. Neurosci. 16 (1994) 90-99
22. Hiraiwa M., Liu J., Lu A.G., Wang C.Y., Misasi R., Yamauchi T., Hozumi I., Inuzuka T., and O'Brien J.S. Regulation of gene expression in response to brain injury: enhanced expression and alternative splicing of rat prosaposin (SGP-1) mRNA in injured brain. Neurotrauma 20 (2003) 755-765
23. O'Brien J.S., Carson G.S., Seo H.C., Hiraiwa M., and Kishimoto Y. Identification of prosaposin as a neurotrophic factor. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 9593-9596
24. O'Brien J.S., Carson G.S., Seo H.C., Hiraiwa M., Weiler S., Tomich J.M., Barranger J.A., Kahn M., Azuma N., and Kishimoto Y. Identification of the neurotrophic factor sequence of prosaposin. FASEB J. 9 (1995) 681-685
25. Kotani Y., Matsuda S., Sakanaka M., Kondoh K., Ueno S., and Sano A. Prosaposin facilitates sciatic nerve regeneration in vivo. J. Neurochem. 66 (1996) 2019-2025
26. Hozumi I., Hiraiwa M., Inuzuka T., Yoneoka Y., Akiyama K., Tanaka R., Kikugawa K., Nakano R., Tsuji S., and O'Brien J.S. Administration of prosaposin ameliorates spatial learning disturbance and reduces cavity formation following stab wounds in rat brain. Neurosci. Lett. 267 (1999) 73-76
27. Sano A., Matsuda S., Wen T.C., Kotani Y., Kondoh K., Ueno S., Kakimoto Y., Yoshimura H., and Sakanaka M. Protection by prosaposin against ischemia-induced learning disability and neuronal loss. Biochem. Biophys. Res. Commun. 204 (1994) 994-1000
28. Yokota N., Uchijima M., Nishizawa S., Namba H., and Koide Y. Identification of differentially expressed genes in rat hippocampus after transient global cerebral ischemia using subtractive cDNA cloning based on polymerase chain reaction. Stroke 32 (2001) 168-174
29. Gillen C., Gleichmann M., Spreyer P., and Muller H.W. Differentially expressed genes after peripheral nerve injury. J. Neurosci. Res. 42 (1995) 159-171
30. Jin K., Sun Y., Xie L., Peel A., Mao X.O., Batteur S., and Greenberg D.A. Directed migration of neuronal precursors into the ischemic cerebral cortex and striatum. Mol. Cell. Neurosci. 24 (2003) 171-189
31. Nakatomi H., Kuriu T., Okabe S., Yamamoto S., Hatano O., Kawahara N., Tamura A., Kirino T., and Nakafuku M. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 110 (2002) 429-441
32. Gopalakrishnan M.M., Grosch H.W., Locatelli-Hoops S., Werth N., Smolenova E., Nettersheim M., Sandhoff K., and Hasilik A. Purified recombinant human prosaposin forms oligomers that bind procathepsin D and affect its autoactivation. Biochem. J. 383 (2004) 507-515
33. Deiss L.P., Galinka H., Berissi H., Cohen O., and Kimchi A. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J. 15 (1996) 3861-3870
34. Pagano S.F., Impagnatiello F., Girelli M., Cova L., Grioni E., Onofri M., Cavallaro M., Etteri S., Vitello F., Giombini S., Solero C.L., and Parati E.A. Isolation and characterization of neural stem cells from the adult human olfactory bulb. Stem Cells 18 (2000) 295-300
35. Ricci-Vitiani L., Pedini F., Mollinari C., Condorelli G., Bonci D., Bez A., Colombo A., Parati E., Peschle C., and De Maria R. Absence of caspase 8 and high expression of PED protect primitive neural cells from cell death. J. Exp. Med. 200 (2004) 1257-1266
36. Vaccaro A.M., Ciaffoni F., Tatti M., Salvioli R., Barca A., Tognozzi D., and Scerch C. pH-dependent conformational properties of saposins and their interactions with phospholipid membranes. J. Biol. Chem. 270 (1995) 30576-30580
37. Yasuda Y., Kageyama T., Akamine A., Shibata M., Kominami E., Uchiyama Y., and Yamamoto K. Characterization of new fluorogenic substrates for the rapid and sensitive assay of cathepsin E and cathepsin D. J. Biochem. (Tokyo) 125 (1999) 1137-1143
38. Vielhaber G., Hurwitz R., and Sandhoff K. Biosynthesis, processing, and targeting of sphingolipid activator protein (SAP)precursor in cultured human fibroblasts. Mannose 6-phosphate receptor-independent endocytosis of SAP precursor. J. Biol. Chem. 271 (1996) 32438-32446
39. Maley F., Trimble R.B., Tarentino A.L., and Plummer Jr. T.H. Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases. Anal. Biochem. 180 (1989) 195-204
40. Trimble R.B., and Tarentino A.L. Identification of distinct endoglycosidase (endo) activities in Flavobacterium meningosepticum: endo F1, endo F2, and endo F3. Endo F1 and endo H hydrolyze only high mannose and hybrid glycans. J. Biol. Chem. 266 (1991) 1646-1651
41. Horst M., and Hasilik A. Expression and maturation of human cathepsin D in baby-hamster kidney cells. Biochem. J. 273 Pt 2 (1991) 355-361
42. Cohen T., Ravid L., Altman N., Madar-Shapiro L., Fein A., Weil M., and Horowitz M. Conservation of expression and alternative splicing in the prosaposin gene. Brain Res. Mol. Brain Res. 129 (2004) 8-19
43. Roisen F.J., Klueber K.M., Lu C.L., Hatcher L.M., Dozier A., Shields C.B., and Maguire S. Adult human olfactory stem cells. Brain Res. 890 (2001) 11-22
44. Igdoura S.A., Hermo L., Rosenthal A., and Morales C.R. Nonciliated cells of the rat efferent ducts endocytose testicular sulfated glycoprotein-1 (SGP-1) and synthesize SGP-1 derived saposins. Anat. Rec. 235 (1993) 411-424
45. von Figura K., and Hasilik A. Lysosomal enzymes and their receptors. Annu. Rev. Biochem. 55 (1986) 167-193
46. Ni X., and Morales C.R. The lysosomal trafficking of acid sphingomyelinase is mediated by sortilin and mannose 6-phosphate receptor. Traffic 7 (2006) 889-902
47. Nykjaer A., Lee R., Teng K.K., Jansen P., Madsen P., Nielsen M.S., Jacobsen C., Kliemannel M., Schwarz E., Willnow T.E., Hempstead B.L., and Petersen C.M. Sortilin is essential for proNGF-induced neuronal cell death. Nature 427 (2004) 843-848
48. Hasilik A. The early and late processing of lysosomal enzymes: proteolysis and compartmentation. Experientia 48 (1992) 130-151
49. Zhu Y., and Conner G.E. Intermolecular association of lysosomal protein precursors during biosynthesis. J. Biol. Chem. 269 (1994) 3846-3851
50. Laurent-Matha V., Lucas A., Huttler S., Sandhoff K., Garcia M., and Rochefort H. Procathepsin D interacts with prosaposin in cancer cells but its internalization is not mediated by LDL receptor-related protein. Exp. Cell Res. 277 (2002) 210-219
51. Fu Q., Carson G.S., Hiraiwa M., Grafe M., Kishimoto Y., and O'Brien J.S. Occurrence of prosaposin as a neuronal surface membrane component. J. Mol. Neurosci. 5 (1994) 59-67
52. Misasi R., Garofalo T., Di Marzio L., Mattei V., Gizzi C., Hiraiwa M., Pavan A., Grazia Cifone M., and Sorice M. Prosaposin: a new player in cell death prevention of U937 monocytic cells. Exp. Cell Res. 298 (2004) 38-47
53. Roberg K., Kagedal K., and Ollinger K. Microinjection of cathepsin d induces caspase-dependent apoptosis in fibroblasts. Am. J. Pathol. 161 (2002) 89-96
54. Bidere N., Lorenzo H.K., Carmona S., Laforge M., Harper F., Dumont C., and Senik A. Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J. Biol. Chem. 278 (2003) 31401-31411
55. Kernie S.G., Erwin T.M., and Parada L.F. Brain remodeling due to neuronal and astrocytic proliferation after controlled cortical injury in mice. J. Neurosci. Res. 66 (2001) 317-326
56. Unwin R.D., and Whetton A.D. Systematic proteome and transcriptome analysis of stem cell populations. Cell Cycle 5 (2006) 1587-1591
57. Ma L., Sun B., Hood L., and Tian Q. Molecular profiling of stem cells. Clin. Chim. Acta 378 (2007) 24-32